The Ukrainian pharmaceutical sector continues to operate amid regular Russian strikes on warehouse, production, and logistics infrastructure. According to the Ministry of Health, despite the risk of facility damage, stock losses, and disrupted supply routes, there is no systemic shortage of medicines in the country. At the same time, the agency records isolated temporary difficulties with the supply of certain drugs, which occur immediately after shelling of warehouses and distribution centers.
Ministry Position: Swift Response Instead of Panic
«There is no systemic shortage of medicines in Ukraine. At the same time, isolated temporary difficulties with the supply of certain drugs do arise,» the Ministry of Health stated. According to the agency's explanation, its current work in cooperation with manufacturers, importers, and distributors focuses on rapidly responding to such disruptions, restoring supplies, and reducing the risk of their recurrence. Thus, the official course is built on the principle of supply continuity: even with local supply chain failures, the state aims to prevent them from escalating into a persistent shortage.
Expanding Storage Capacities: Resolution No. 1062
To reduce the risk of simultaneous loss of large inventories, the government expanded options for receiving, storing, and shipping medicines from additional warehouse facilities. The corresponding Cabinet of Ministers Resolution No. 1062 of August 26, 2026, allows companies under certain conditions to use premises whose details are absent from the licensing registry or belong to another licensee. At the same time, mandatory compliance with quality and traceability requirements is maintained, preventing a lowering of standards amid logistics simplification.
Simplifying Import Control: Resolution No. 1254
The second key change was approved by Resolution No. 1254 of October 13, 2026. The document concerns state quality control of medicines imported into Ukraine and provides for the simplification of certain inspection procedures for imported drugs, as well as special control conditions for the re-importation of the same batch. The Ministry of Health explains that these decisions are designed to deliver medicines to pharmacies and medical facilities faster and support supply continuity without weakening drug quality requirements.
Broader Context: Medical Institution Autonomy and Scientific Base
Pharmaceutical logistics measures fit into a broader healthcare resilience plan. As of early October 2026, 78% of medical facilities in Ukraine's capable network could already operate fully autonomously during power, heat, and water outages. Simultaneously, the country preserves its scientific potential in pharmaceuticals: back in 2021, Ukrainian scientists developed a COVID-19 vaccine prototype that showed 93% neutralizing activity in animal tests, although further development was paused. According to authorities, the combination of these factors helps keep the medicine market operational even under ongoing attacks on infrastructure.
